Questions and answers with Alexandre Mebazaa and Dominique Bettex following their presentations during the satellite symposium ‘Securing more time and balance in critical care’ on 22 March 2017 during the 37th ISICEM meeting in Brussels, sponsored by Orion Pharma.
Dr Alexandre Mebazaa shares data from recent publications exploring the multiple effects of levosimendan.
Dr Alexandre Mebazaa discusses the inotropic and decongestive effects of levosimendan in heart failure and cardiogenic shock, in the light of recent studies.
Alternatively login via
Back to epgonline.org